Literature DB >> 8821769

Increased collagen content of cerebral microvessels in Alzheimer's disease.

R N Kalaria1, A B Pax.   

Abstract

Based on previous evidence suggesting abnormalities in the brain microvasculature, we examined basement membrane collagen in isolated cerebral microvessels (CMV) from subjects with Alzheimer's disease (AD) and age-matched controls. Concentrations of hydroxyproline, the principal constituent of collagen IV, were significantly increased by 55% in CMV from AD subjects compared to controls. This result was corroborated by the finding of 60% increased total collagen content in CMV as evident by the selective binding of Sirius red dye. Hydroxyproline and collagen concentrations in samples of cerebral cortex assayed in parallel were 6-20 times smaller than in CMV and were not changed between controls and AD subjects. To further differentiate AD and control samples, fractions of CMV were solubilized and the pepsin digested collagen proteins resolved by SDS-PAGE. Upon immunoblotting, AD samples with increased collagen revealed proportionally greater specific immunoreactivities detected by antibodies to collagen IV. Our observations suggest altered collagen IV content of cerebral vessels in subjects with AD that may affect brain microvascular functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821769     DOI: 10.1016/0006-8993(95)01250-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  49 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

Review 2.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

3.  Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment.

Authors:  Ulla Milbreta; Ysander von Boxberg; Philippe Mailly; Fatiha Nothias; Sylvia Soares
Journal:  J Neurotrauma       Date:  2014-03-31       Impact factor: 5.269

4.  Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

Authors:  Petra Majerova; Ralph M Garruto; Andrej Kovac
Journal:  J Neural Transm (Vienna)       Date:  2018-04-26       Impact factor: 3.575

5.  Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition.

Authors:  Daniel S Heffron; Gary E Landreth; Ivy S Samuels; James W Mandell
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

6.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

Review 7.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

8.  Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia.

Authors:  Nino Muradashvili; Reeta Tyagi; Naira Metreveli; Suresh C Tyagi; David Lominadze
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-28       Impact factor: 6.200

9.  Supplementation of deprenyl attenuates age associated alterations in rat cerebellum.

Authors:  Manju V Subramanian; T J James
Journal:  Mol Biol Rep       Date:  2010-03-07       Impact factor: 2.316

10.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings.

Authors:  Bliss Elizabeth O'Bryhim; Rajendra S Apte; Nathan Kung; Dean Coble; Gregory P Van Stavern
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.